Results 161 to 170 of about 64,509,941 (193)

Biologics for eosinophilic granulomatosis with polyangiitis

Current Opinion in Allergy & Clinical Immunology, 2022
Purpose of review The link between severe asthma and eosinophilic granulomatosis with polyangiitis (EGPA) in terms of pathophysiological background, clinical manifestations and disease evolution has leaded to investigate the relevance of anti T2 monoclonal antibodies licensed for severe asthma patients as a treatment option for
Caminati, Marco, Maule, Matteo, Bello, Federica, Emmi, Giacomo   +3 more
openaire   +4 more sources

Benralizumab for eosinophilic granulomatosis with polyangiitis

Annals of the Rheumatic Diseases, 2023
Benralizumab is effective in the treatment of eosinophilic asthma and is being investigated for the treatment of other eosinophil-associated diseases. Reports on the use of benralizumab for the treatment of eosinophilic granulomatosis with polyangiitis (EGPA) are limited to case reports and small case series.We conducted a multicentre, retrospective ...
Cottu, Adrien, Groh, Matthieu, Desaintjean, Charlene, Marchand-Adam, Sylvain, Guillevin, Loïc, Puechal, Xavier, Beaumesnil, Stacy, Lazaro, Estibaliz, Samson, Maxime, Taille, Camille, Durel, Cécile-Audrey, Diot, Elizabeth, Nicolas, Sarah, Guilleminault, Laurent, Ebbo, Mikael, Cathebras, Pascal, Dupin, Clairelyne, Yildiz, Halil, Belfeki, Nabil, Pugnet, Grégory, Chauvin, Pierre, Jouneau, Stephane, Lifermann, Francois, Martellosio, Jean-Philippe, Cottin, Vincent, Terrier, Benjamin   +25 more
openaire   +2 more sources

Targeting Eosinophils in Eosinophilic Granulomatosis with Polyangiitis

New England Journal of Medicine, 2017
Eosinophilic granulomatosis with polyangiitis, first described in the early 1950s by Dr. Jacob Churg and Dr. Lotte Strauss (hence the original name, the Churg–Strauss syndrome), is a rare condition that can affect many organ systems, most commonly the lung, with the majority of patients presenting with asthma symptoms, occasionally complicated by the ...
Djukanović, Ratko, O'Byrne, Paul
openaire   +2 more sources

Eosinophilic granulomatosis with polyangiitis

Folia Otorhinolaryngologiae et Pathologiae Respiratoriae
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare systemic disease in the group of ANCA-associated vasculitides, characterized by a combination of severe eosinophilic asthma, chronic rhinosinusitis, hypereosinophilia, and necrotizing vasculitis of small and medium-sized vessels.
Alexandra M. Nanzer, Francesca Cefaloni, Jessica Gates, Faizan Haris, Jaideep Dhariwal, David J. Jackson   +5 more
  +4 more sources

Eosinophilic Granulomatosis With Polyangiitis

JAMA Dermatology, 2021
Abraham M, Korman, Catherine G, Chung
openaire   +2 more sources

Gynecological involvement in eosinophilic granulomatosis with polyangiitis

International Journal of Rheumatic Diseases, 2016
AbstractGynceological involvement in antineutrophil cytoplasmic antibody (ANCA)‐associated vasculitides is rare. We describe a case of ANCA‐associated vasculitis in an elderly woman presenting with fevers, cough and a rash. Further investigations revealed vasculitic involvement of the ovaries, fallopian tubes, uterus and omentum with an eosinophil‐rich
Aishwarya, Sukhdeo, James, Bertouch
openaire   +2 more sources

Eosinophilic fasciitis in eosinophilic granulomatosis with polyangiitis

Rheumatology, 2023
Ole Hudowenz, Sabrina Arnold, Inge Derad, Peter Lamprecht   +3 more
openaire   +2 more sources

Aortitis in Eosinophilic Granulomatosis With Polyangiitis

JCR: Journal of Clinical Rheumatology, 2023
Hirotaka, Yamamamoto, Yoshinori, Taniguchi   +1 more
openaire   +2 more sources

Benralizumab in eosinophilic granulomatosis with polyangiitis

Medicina Clínica, 2022
Daniel, Laorden, David, Romero, Javier, Domínguez-Ortega   +2 more
openaire   +2 more sources

Eosinophilic Granulomatosis with Polyangiitis: Latest Findings and Updated Treatment Recommendations

Journal of Clinical Medicine, 2023
Ryu Watanabe, Motomu Hashimoto
exaly